Precision-Panc are delighted that PRIMUS 006 has opened to recruitment. Read all about t below. Currently Glasgow open to recruitment but many more UK sites to come
🆕 .@UofGlasgow, alongside @NHSGGC, has opened the PRIMUS-006 pancreatic cancer study, part of the @precisionpanc platform.
The Phase II study will evaluate a new drug combination as first-line treatment in patients with metastatic pancreatic cancer.
➡️ https://t.co/Nq6IEE6A34
Clinical trials can be an important option for people with #PancreaticCancer and are also crucial for developing new treatments for this devastating disease.
We're pleased to see the Government making progress in speeding up the time it takes to set up new clinical trials.
🧬 University of Glasgow spin-out has secured £1.6M in funding to launch AI tech that learns the ‘language of cancer’ — accelerating diagnosis and unlocking new insights for treatment
📍 @UofGlasgow
👇 Learn more
https://t.co/lE7PWsUtEN
Today marks the first day of Less Survivable Cancers Awareness Week.
This week, @LessSurvivable will be sharing shocking figures on the research gap, encouraging you to take action, and showcasing what research can do for Less Survivable Cancers.
#CloseTheResearchGap
We’re at Glasgow Central Station today raising awareness of pancreatic cancer. 💜
🗓 25 Nov | ⏰ 8am–6pm
🎶 Entertainment all day:
11am Rock Choir
11.45 Rock Choir
2pm KC Community Choir
3pm Whyte Noise
5pm Kirkintilloch Pipe Band
If you're passing through, come say hi!
We’re inviting international, multidisciplinary teams to propose creative approaches to address some of the toughest questions in cancer research.
🗓️ EOIs close 18 June
🔗 Apply now: https://t.co/lYqOkRWH92
#CancerGrandChallenges
Today the public has rallied behind us as we have powerfully demonstrated the devastating impact of #PancreaticCancer in the UK.
It is unacceptable that 797 people die of this cruel disease every month. We need to do more.
Early detection is vital to improve survival rates.
.@UofGlasgow researchers are among the team of European clinicians and scientists who form CRC-STARS, a world-leading research team tasked with making personalised medicine a reality for people with bowel cancer.
@CRUKresearch@BowelbabeF@UofGMVLS
➡️ https://t.co/g3nbRqkDw1
⏳ Closing soon! Complete by April 17th ✅
Queen's University Belfast & NIPANC are surveying the needs of those supporting a loved one with #pancreaticcancer. Your input can help shape future support!
🔗 Participate: https://t.co/0DQH6Zqkbm
Thank you to our amazing supporters who spoke to over 70 MPs in Parliament today about the need to #EndPERTShortages. Pancreatic Enzyme Replacement Therapy (PERT) is essential for people with #PancreaticCancer: we won’t stop campaigning until everyone who needs PERT can get it.
💜 Fighting for early diagnosis!
Our founder and spokesperson Ali Stunt spoke at the European Parliament's PANCAID event, advocating for research to develop early detection tools for pancreatic cancer. Let's drive change together.
🔗 Read more: https://t.co/w5RA0ix7TP
🏆 We are incredibly proud to announce that the @UofGCancerSci has been awarded the prestigious Athena Swan Gold Award from Advance HE! 🏆
Explore https://t.co/16ZRtdoK3E
#MVLS
Register for our seminar on #imaging innovation on the 20th of March!
Join us as we explore cutting-edge imaging technologies, address key challenges in clinical adoption, and connect with peers to spark new collaborations.
📢 Registration is open!
🔗: https://t.co/596HxlQpTn
Today is #WorldCancerDay.
@UofGlasgow & Glasgow city are pioneers in cancer research & treatment. Hear from Head of School, Prof Chris Halsey, about the innovations from last 50 years of @UofGCancerSci 🔬
Support cancer sciences at UofG: https://t.co/guJXprSs8Q
@UofGMVLS
We are delighted to see @GwynneMP committing to improving outcomes for those with less survivable cancers. Greater research is key to developing better treatments. https://t.co/ph4hcScZQw
Our team brought #PrecisionMedicine to life at St Paul's High School this week!🧬
We spoke with young people and their families about what precision medicine is, the exciting career opportunities it offers, and how to explore pathways into their preferred fields.
#STEMCareers
New @JAMANetworkOpen study by @GarridoLagunaMD in collaboration with @FoundationATCG@flatironhealth on the impact of KRAS allelic status on outcomes in #PancreaticCancer.
In ~2500 patients, those with wild type KRAS have the most favorable outcomes followed by G12R and then G12V/G12D (“favorable” is relative). The co-mutation frequencies of each KRAS allele is highlighted, which reiterates KRAS WT (often alternative driver with fusions) is a pretty much different disease with low frequencies of CDKN2A, p53 & SMAD4 mutations (the big three TSGs).
It's the first day of Less Survivable Cancers Awareness Week and as one of the less survivable cancers we want to amplify the urgent need for more research into early detection methods and better treatment for those affected by pancreatic cancer.
https://t.co/gZFyJHtDHd